Vudalimab
Product Specifications
CAS Number
2329669-72-7
Target
PD-1/PD-L1
Related Pathways
Immunology/Inflammation, Apoptosis, Cell Cycle/Checkpoint
Bioactivity
Vudalimab, a fully humanized bispecific monoclonal antibody, effectively inhibits both PD-1 and CTLA-4 immune checkpoint receptors. This dual action facilitates the selective activation of T-cells targeting tumors.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6357601-01 0.1 mL
TPC6A, NT (TRAPPC6A, Trafficking protein particle complex subunit 6A) (MaxLight 650)
Sign In for Pricing
View Details MBS6357601-02 5x 0.1 mL
TPC6A, NT (TRAPPC6A, Trafficking protein particle complex subunit 6A) (MaxLight 650)
Sign In for Pricing
View Details 